Diplomat Pharmacy Inc. (DPLO) Plunges 5.09% on December 06

Diplomat Pharmacy Inc. (DPLO) Plunges 5.09% on December 06

Diplomat Pharmacy Inc. (DPLO) had a rough trading day for Thursday December 06 as shares tumbled 5.09%, or a loss of $-0.8 per share, to close at $14.92. After opening the day at $15.36, shares of Diplomat Pharmacy Inc. traded as high as $15.49 and as low as $14.60. Volume was 915,732 shares over 8,265 trades, against an average daily volume of 1.08 million shares and a total float of 74.47 million.

As a result of the decline, Diplomat Pharmacy Inc. now has a market cap of $1.11 billion.

The stock has a P/E Ratio of 372.

In the last year, shares of Diplomat Pharmacy Inc. have traded between a range of $28.74 and $13.31, and its 50-day SMA is currently $18.13 and 200-day SMA is $21.27.

Diplomat Pharmacy Inc is active within United States’ healthcare sector. It offers a range of services related to medical care, especially pharmacy solutions for chronic diseases such as hepatitis, multiple sclerosis, and other long-term conditions. Furthermore, it renders clinical services, drug-specific compliance, and persistency programs support, patient financial assistance and clinical and administrative support services to hospitals. The company derives most of its revenue through prescription drug sales in the United States.

Diplomat Pharmacy Inc. is based out of Flint, MI and has some 2,419 employees. Its CEO is Brian T. Griffin.

error: Content is protected !!